These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 37058189)

  • 21. Single-Site Nanozymes with a Highly Conjugated Coordination Structure for Antitumor Immunotherapy via Cuproptosis and Cascade-Enhanced T Lymphocyte Activity.
    Liu Y; Niu R; Zhao H; Wang Y; Song S; Zhang H; Zhao Y
    J Am Chem Soc; 2024 Feb; 146(6):3675-3688. PubMed ID: 38305736
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lipoxygenase-mediated pro-radical effect of melatonin via stimulation of arachidonic acid metabolism.
    Radogna F; Sestili P; Martinelli C; Paolillo M; Paternoster L; Albertini MC; Accorsi A; Gualandi G; Ghibelli L
    Toxicol Appl Pharmacol; 2009 Jul; 238(2):170-7. PubMed ID: 19460395
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multi-Enzyme Mimetic MoCu Dual-Atom Nanozyme Triggering Oxidative Stress Cascade Amplification for High-Efficiency Synergistic Cancer Therapy.
    Li Z; Ding B; Li J; Chen H; Zhang J; Tan J; Ma X; Han D; Ma P; Lin J
    Angew Chem Int Ed Engl; 2024 Aug; ():e202413661. PubMed ID: 39166420
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An all-in-one biomimetic iron-small interfering RNA nanoplatform induces ferroptosis for cancer therapy.
    Huang S; Le H; Hong G; Chen G; Zhang F; Lu L; Zhang X; Qiu Y; Wang Z; Zhang Q; Ouyang G; Shen J
    Acta Biomater; 2022 Aug; 148():244-257. PubMed ID: 35709941
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pro-ferroptotic fatty acid metabolism renders cancer cells immunogenic.
    Kepp O; Kroemer G
    Trends Cancer; 2022 Oct; 8(10):785-787. PubMed ID: 35469799
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phospholipase A2 treatment of lymphocytes provides helper signal for interferon-gamma induction. Evidence for second messenger role of endogenous arachidonic acid.
    Russell JK; Torres BA; Johnson HM
    J Immunol; 1987 Nov; 139(10):3442-6. PubMed ID: 3119709
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oxygen Self-Generating Nanoreactor Mediated Ferroptosis Activation and Immunotherapy in Triple-Negative Breast Cancer.
    Li K; Xu K; He Y; Yang Y; Tan M; Mao Y; Zou Y; Feng Q; Luo Z; Cai K
    ACS Nano; 2023 Mar; 17(5):4667-4687. PubMed ID: 36861638
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combination of ferroptosis and pyroptosis dual induction by triptolide nano-MOFs for immunotherapy of Melanoma.
    Wang S; Guo Q; Xu R; Lin P; Deng G; Xia X
    J Nanobiotechnology; 2023 Oct; 21(1):383. PubMed ID: 37858186
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Degradable iron-rich mesoporous dopamine as a dual-glutathione depletion nanoplatform for photothermal-enhanced ferroptosis and chemodynamic therapy.
    Cheng H; He Y; Lu J; Yan Z; Song L; Mao Y; Di D; Gao Y; Zhao Q; Wang S
    J Colloid Interface Sci; 2023 Jun; 639():249-262. PubMed ID: 36805750
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anti-PD-L1 DNAzyme Loaded Photothermal Mn
    Liu P; Shi X; Peng Y; Hu J; Ding J; Zhou W
    Adv Healthc Mater; 2022 Apr; 11(8):e2102315. PubMed ID: 34841741
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tetrahydrobiopterin inhibitor-based antioxidant metabolic strategy for enhanced cancer ferroptosis-immunotherapy.
    Liu Z; Kang R; Yang N; Pan X; Yang J; Yu H; Deng W; Jia Z; Zhang J; Shen Q
    J Colloid Interface Sci; 2024 Mar; 658():100-113. PubMed ID: 38100967
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Programmed Targeting Pyruvate Metabolism Therapy Amplified Single-Atom Nanozyme-Activated Pyroptosis for Immunotherapy.
    Niu R; Liu Y; Xu B; Deng R; Zhou S; Cao Y; Li W; Zhang H; Zheng H; Song S; Wang Y; Zhang H
    Adv Mater; 2024 Jun; 36(24):e2312124. PubMed ID: 38314930
    [TBL] [Abstract][Full Text] [Related]  

  • 33. GSH/APE1 Cascade-Activated Nanoplatform for Imaging Therapy Resistance Dynamics and Enzyme-Mediated Adaptive Ferroptosis.
    Yue R; Zhou M; Li X; Xu L; Lu C; Dong Z; Lei L; Liu H; Guan G; Liu Q; Zhang XB; Song G
    ACS Nano; 2023 Jul; 17(14):13792-13810. PubMed ID: 37458417
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Amorphous ferric oxide-coating selenium core-shell nanoparticles: a self-preservation Pt(IV) platform for multi-modal cancer therapies through hydrogen peroxide depletion-mediated anti-angiogenesis, apoptosis and ferroptosis.
    Xu Z; Li Q; Zhang C; Wang P; Xu X; Ran L; Zhang L; Tian G; Zhang G
    Nanoscale; 2022 Aug; 14(32):11600-11611. PubMed ID: 35861683
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A tumor microenvironment responsive nanoplatform with oxidative stress amplification for effective MRI-based visual tumor ferroptosis.
    Luo S; Ma D; Wei R; Yao W; Pang X; Wang Y; Xu X; Wei X; Guo Y; Jiang X; Yuan Y; Yang R
    Acta Biomater; 2022 Jan; 138():518-527. PubMed ID: 34775124
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Self-Adaptive Single-Atom Catalyst Boosting Selective Ferroptosis in Tumor Cells.
    Cao F; Sang Y; Liu C; Bai F; Zheng L; Ren J; Qu X
    ACS Nano; 2022 Jan; 16(1):855-868. PubMed ID: 35025200
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Artesunate carriers induced ferroptosis to overcome biological barriers for anti-cancer.
    Huang QF; Li YH; Huang ZJ; Jun M; Wang W; Chen XL; Wang GH
    Eur J Pharm Biopharm; 2023 Sep; 190():284-293. PubMed ID: 37532638
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Three-Step Depletion Strategy of Glutathione: Tunable Metal-Organic-Framework-Engineered Nanozymes for Driving Oxidative/Nitrative Stress to Maximize Ferroptosis Therapy.
    Li W; Liu S; Ding H; Zhao R; Zang P; Li S; Fang L; Li R; Zhang M; Yang P
    Nano Lett; 2024 Feb; 24(6):2071-2080. PubMed ID: 38305186
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An ROS-Activatable Nanoassembly Remodulates Tumor Cell Metabolism for Enhanced Ferroptosis Therapy.
    Zhang Y; Li L; Li Y; Fei Y; Xue C; Yao X; Zhao Y; Wang X; Li M; Luo Z
    Adv Healthc Mater; 2022 Jan; 11(2):e2101702. PubMed ID: 34710950
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interferon-gamma induces the synthesis and activation of cytosolic phospholipase A2.
    Wu T; Levine SJ; Lawrence MG; Logun C; Angus CW; Shelhamer JH
    J Clin Invest; 1994 Feb; 93(2):571-7. PubMed ID: 8113394
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.